Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy
about
A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophyPeripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy.Muscle matters in Kennedy's disease.The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solutionDifferential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease.Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: molecular and functional evaluation in hindlimb unloaded MLC/mIgf-1 transgenic miceMechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy.Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer.Spinal and Bulbar Muscular Atrophy Overview.Trinucleotide repeats and protein folding and disease: the perspective from studies with the androgen receptor.Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.New routes to therapy for spinal and bulbar muscular atrophy.Potential therapeutic targets in polyglutamine-mediated diseases.Targeted Molecular Therapies for SBMA.Polyglutamine androgen receptor-mediated neuromuscular disease.Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.Post-translational Modifications and Protein Quality Control in Motor Neuron and Polyglutamine Diseases.Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease.Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy.Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans.Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy.
P2860
Q28391475-E5AA549B-F9D2-4F57-8574-EDE55B7A7F3BQ30405294-FCB6E1E9-2EDF-4AC0-811B-969733E1E637Q33860974-25AB0E8A-4221-4BDC-A739-C5B607398E9EQ33980214-66CA48B2-58E3-46AD-8F2A-274578F287E0Q34537073-72855590-124D-4ACD-96A8-DB17940B8B44Q34766154-006A8958-EC62-4F74-AC17-23B96FC8A738Q36844932-F2BCFB49-9DE5-4D64-B669-5750F3C3C913Q36939759-9502F6C2-96BF-4EEF-A31C-CE1424171EB3Q37334160-20DC572E-EFE6-4DCB-8383-EFD7CDD86F3BQ37392206-B79B732E-DE53-4968-A56E-263DF51C1CB7Q37474263-4CD0D2E5-7CBD-4911-AD29-A874984D5F1FQ37572139-B0440995-32D5-48C9-AB2D-51601D852C95Q37602169-886305EF-9EE8-4BC8-8353-0CAE66AC6E81Q38082664-9AC2FEFA-C2A7-49E3-AB4B-CD24E272DF87Q38246221-F568DE66-DAAF-479F-A0CE-4538C467C6B9Q38635851-942B0008-6F68-4E79-8EFA-AE6CBA5381EDQ38836469-CE3B044C-8E74-486B-AA67-C060794FB479Q39219980-CB7A76F1-5C43-4262-A83D-68E21A20CE7EQ39241744-CAC85B2E-3063-40F0-8798-57946D4F3156Q45146825-2872B81F-DDDB-4913-B0FC-028557FBC6AEQ47105153-CB6658FC-9250-4C5F-8BC0-D179E338F9A5Q47194979-85D51727-B09E-4D37-B0EF-76E735CE1DFCQ53399356-2376591D-8871-45A7-971A-70475811D454
P2860
Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@ast
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@en
Insulinlike growth factor
@nl
type
label
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@ast
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@en
Insulinlike growth factor
@nl
prefLabel
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@ast
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@en
Insulinlike growth factor
@nl
P2093
P2860
P1433
P1476
Insulinlike growth factor (IGF ...... al and bulbar muscular atrophy
@en
P2093
Carlo Rinaldi
George G Harmison
Ke-lian Chen
Kenneth H Fischbeck
Laura C Bott
Maria Pennuto
Masahisa Katsuno
P2860
P2888
P304
P356
10.2119/MOLMED.2012.00271
P407
P50
P577
2012-12-06T00:00:00Z
P5875
P6179
1068965561